Clinical outcomes and staff satisfaction after adoption of digital chest drainage system for minimally invasive lung resections.

Background: Digital chest drainage systems (DCDS) provide reliable pleural drainage while quantifying fluid output and air leak. However, the benefits of DCDS in the contemporary era of minimally invasive thoracic surgery and enhanced recovery after surgery (ERAS) protocols have not been fully investigated. Additionally, hospital and resident staff experiences after implementation of a DCDS have not been fully explored. The objective of this study was to evaluate the clinical outcomes and hospital staff experience after adoption of a DCDS for minimally invasive lung resections. Methods: A single-center retrospective review of patients who underwent minimally invasive lung resection (lobectomy, segmentectomy, and wedge resection) and received a DCDS from 11/1/2021 to 11/1/2022. DCDS patients were compared to sequential historical controls (3/1/2019-6/30/2021) who received a analog chest drainage system. For the analog system, chest tubes were removed when no bubbles were observed in the water seal compartment with Valsalva, cough, and in variable positions. With a DCDS, chest tubes were removed when the air leak was less than 30 cc/min for 8 hours, with no spikes. All patients followed an institutional ERAS protocol. Primary outcomes were length of stay (LOS) and chest tube duration. Hospital staff and residents were surveyed regarding their experience. Results: One hundred and twenty-four patients received DCDS, and 248 received an analog chest drainage system. There was a reduction in mean LOS (3.6 vs. 4.4 days, P=0.01) and chest tube duration (2.7 vs. 3.6 days, P=0.03) in the DCDS group. Hospital staff (n=77, 46% response rate) reported the DCDS easier to use (60%, P<0.001) and easier to care for patients with (65%, P<0.001) compared to the analog system. Surgical residents (n=28, 56% response rate) reported increased confidence in interpretation of air leak (75%, P<0.001) and decision-making surrounding chest tube removal (79%, P<0.001). Conclusions: Using a DCDS can reduce LOS and chest tube duration in the contemporary setting of minimally invasive lung resections and ERAS protocols. Increased confidence of resident decision-making for chest tube removal may contribute to improved outcomes.

COVID-19-induced Esophageal Necrosis Requiring Emergent Total Esophagectomy in a Vaccinated Patient.

Acute esophageal necrosis may be a potential complication of Coronavirus Disease 2019 (COVID-19). COVID-19 has been associated with a variety of sequelae, including acute respiratory distress syndrome, myocarditis, and thromboembolic events. Here, we present a case of a 43-year-old male who was admitted for acute necrotizing pancreatitis and found to have COVID-19 pneumonia. He subsequently developed acute esophageal necrosis requiring a total esophagectomy. Currently, there are at least five other reported cases of esophageal necrosis with concomitant COVID-19 infection. This case is the first requiring esophagectomy. Future studies may establish esophageal necrosis as a known complication of COVID-19.

Posterior Ethmomaxillary Cells: Anatomical Variation to be Considered in Endoscopic Sinus Surgery.

To identify the posterior ethmomaxillary (PEM) cells on computed tomographic scans for complete sinus clearance during endoscopic sinus surgery to prevent disease recurrence. Prospective single institution study. MAA ENT Hospitals Pvt. Ltd., Hyderabad. 350 patients were selected for the study. Computed tomographic scans of these patients were performed suffering from chronic rhinosinusitis and requiring endoscopic sinus surgery (primary or revision cases). The scans were evaluated and presence of PEM cells was noted. These findings were co-related intra-operatively and above-mentioned cells were opened. In revision cases, these cells were left unopened in previous cases and were cleared in present surgery and the patients were followed up for recurrence. A total number of 350 CT scans of nose and para-nasal sinus were studied. There were 176 males and 174 were females. The presence of PEM cells was 11.42% with bilaterality in 80%. In revision cases, it was 23%. PEM cells act as hidden areas in the para-nasal sinus and if not identified and cleared, it acts as a nidus for disease recurrence and cause for failure of surgery. Identification of PEM is important during surgery for complete disease clearance. As very little information exists in the current literature, we are submitting this study to enlighten Rhinologist regarding PEM cells.

Giant Cell Tumour of Hard Palate and its Surgical Management: Case Report.

The giant cell tumour is a benign but locally aggressive tumour accounting for 5% of all bone tumours typically seen at the metaphyseo-epiphyseal ends of long bones with 1% incidence in skull bones. We are presenting a case report of 40 year old female with GCT of hard palate. An initial pre-operative plan was hard palate removal with complete tumour clearance trans-orally with iatrogenic oro-nasal fistula with rehabilitation to be done with obturator for closure of fistula and dentures to aid chewing. However, intra-operatively the surgical plan was revised and the tumour was removed with preservation of party wall mucosa. Thus, we present this case due to its clinical rarity and academic interest.